Literature DB >> 22927442

Three different functional microdomains in the hepatitis C virus hypervariable region 1 (HVR1) mediate entry and immune evasion.

Mo Guan1, Wenbo Wang, Xiaoqing Liu, Yimin Tong, Yuan Liu, Hao Ren, Shiying Zhu, Jean Dubuisson, Thomas F Baumert, Yongzhe Zhu, Haoran Peng, Laure Aurelian, Ping Zhao, Zhongtian Qi.   

Abstract

High genetic heterogeneity is an important characteristic of hepatitis C virus (HCV) that contributes to its ability to establish persistent infection. The hypervariable region 1 (HVR1) that includes the first 27 amino acid residues of the E2 envelope glycoprotein is the most variable region within the HCV polyprotein. HVR1 plays a major role in both HCV cell entry and immune evasion, but the respective contribution of specific amino acid residues is still unclear. Our mutagenesis analyses of HCV pseudoparticles and cell culture-derived HCV using the H77 isolate indicate that five residues at positions 14, 15, and 25-27 mediate binding of the E2 protein to the scavenger receptor class B, type I receptor, and any residue herein is indispensable for HCV cell entry. The region spanning positions 16-24 contains the sole neutralizing epitope and is dispensable for HCV entry, but it is involved in heparan binding. More importantly, this region is necessary for the enhancement of HCV entry by high density lipoprotein and interferes with virus neutralization by E2-neutralizing antibodies. Residues at positions 1-13 are also dispensable for HCV entry, but they can affect HCV infectivity by modulating binding of the envelope protein to scavenger receptor class B, type I. Mutations occurring at this site may confer resistance to HVR1 antibodies. These findings further our understanding about the mechanisms of HCV cell entry and the significance of HVR1 variation in HCV immune evasion. They have major implications for the development of HCV entry inhibitors and prophylactic vaccines.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22927442      PMCID: PMC3471721          DOI: 10.1074/jbc.M112.382341

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  69 in total

1.  An interplay between hypervariable region 1 of the hepatitis C virus E2 glycoprotein, the scavenger receptor BI, and high-density lipoprotein promotes both enhancement of infection and protection against neutralizing antibodies.

Authors:  Birke Bartosch; Géraldine Verney; Marlène Dreux; Peggy Donot; Yoann Morice; François Penin; Jean-Michel Pawlotsky; Dimitri Lavillette; Francois-Loïc Cosset
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

2.  Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1.

Authors:  Jean-Christophe Meunier; Ronald E Engle; Kristina Faulk; Ming Zhao; Birke Bartosch; Harvey Alter; Suzanne U Emerson; Francois-Loic Cosset; Robert H Purcell; Jens Bukh
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-14       Impact factor: 11.205

3.  Antibody responses to hepatitis C virus hypervariable region 1: evidence for cross-reactivity and immune-mediated sequence variation.

Authors:  M U Mondelli; A Cerino; A Lisa; S Brambilla; L Segagni; A Cividini; M Bissolati; G Missale; G Bellati; A Meola; B Bruniercole; A Nicosia; G Galfrè; E Silini
Journal:  Hepatology       Date:  1999-08       Impact factor: 17.425

4.  Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81.

Authors:  M Flint; C Maidens; L D Loomis-Price; C Shotton; J Dubuisson; P Monk; A Higginbottom; S Levy; J A McKeating
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

5.  Binding of hepatitis C virus to CD81.

Authors:  P Pileri; Y Uematsu; S Campagnoli; G Galli; F Falugi; R Petracca; A J Weiner; M Houghton; D Rosa; G Grandi; S Abrignani
Journal:  Science       Date:  1998-10-30       Impact factor: 47.728

6.  Sulfated homologues of heparin inhibit hepatitis C virus entry into mammalian cells.

Authors:  Arnab Basu; Tatsuo Kanda; Aster Beyene; Kousuke Saito; Keith Meyer; Ranjit Ray
Journal:  J Virol       Date:  2007-02-07       Impact factor: 5.103

Review 7.  Epidemiology of hepatitis C virus infection.

Authors:  Miriam J Alter
Journal:  World J Gastroenterol       Date:  2007-05-07       Impact factor: 5.742

8.  Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry.

Authors:  Matthew J Evans; Thomas von Hahn; Donna M Tscherne; Andrew J Syder; Maryline Panis; Benno Wölk; Theodora Hatziioannou; Jane A McKeating; Paul D Bieniasz; Charles M Rice
Journal:  Nature       Date:  2007-02-25       Impact factor: 49.962

9.  Hepatitis C virus epitope-specific neutralizing antibodies in Igs prepared from human plasma.

Authors:  Pei Zhang; Charles G Wu; Kathleen Mihalik; Maria Luisa Virata; Mei-Ying W Yu; Harvey J Alter; Stephen M Feinstone
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-09       Impact factor: 11.205

10.  Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C.

Authors:  Jan M Pestka; Mirjam B Zeisel; Edith Bläser; Peter Schürmann; Birke Bartosch; Francois-Loïc Cosset; Arvind H Patel; Helga Meisel; Jens Baumert; Sergei Viazov; Kay Rispeter; Hubert E Blum; Michael Roggendorf; Thomas F Baumert
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-28       Impact factor: 11.205

View more
  25 in total

1.  Hypervariable region 1 shielding of hepatitis C virus is a main contributor to genotypic differences in neutralization sensitivity.

Authors:  Jannick Prentoe; Rodrigo Velázquez-Moctezuma; Steven K H Foung; Mansun Law; Jens Bukh
Journal:  Hepatology       Date:  2016-08-09       Impact factor: 17.425

2.  Altered Glycosylation Patterns Increase Immunogenicity of a Subunit Hepatitis C Virus Vaccine, Inducing Neutralizing Antibodies Which Confer Protection in Mice.

Authors:  Dapeng Li; Markus von Schaewen; Xuesong Wang; Wanyin Tao; Yunfang Zhang; Li Li; Brigitte Heller; Gabriela Hrebikova; Qiang Deng; Alexander Ploss; Jin Zhong; Zhong Huang
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

3.  Non-neutralizing epitopes induce robust hepatitis C virus (HCV)-specific antibody-dependent CD56+ natural killer cell responses in chronic HCV-infected patients.

Authors:  L Long; M Jia; X Fan; H Liang; J Wang; L Zhu; Z Xie; T Shen
Journal:  Clin Exp Immunol       Date:  2017-04-07       Impact factor: 4.330

4.  Transmission and evolution of hepatitis C virus in HCV seroconverters in HIV infected subjects.

Authors:  Chengli Shen; Phalguni Gupta; Xiaochuan Xu; Anwesha Sanyal; Charles Rinaldo; Eric Seaberg; Joseph B Margolick; Otoniel Martinez-Maza; Yue Chen
Journal:  Virology       Date:  2013-12-22       Impact factor: 3.616

5.  Synergistic anti-HCV broadly neutralizing human monoclonal antibodies with independent mechanisms.

Authors:  Madeleine C Mankowski; Valerie J Kinchen; Lisa N Wasilewski; Andrew I Flyak; Stuart C Ray; James E Crowe; Justin R Bailey
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-18       Impact factor: 11.205

6.  Network Analysis of the Chronic Hepatitis C Virome Defines Hypervariable Region 1 Evolutionary Phenotypes in the Context of Humoral Immune Responses.

Authors:  Brendan A Palmer; Daniel Schmidt-Martin; Zoya Dimitrova; Pavel Skums; Orla Crosbie; Elizabeth Kenny-Walsh; Liam J Fanning
Journal:  J Virol       Date:  2015-12-30       Impact factor: 5.103

7.  Analysis of the evolution and structure of a complex intrahost viral population in chronic hepatitis C virus mapped by ultradeep pyrosequencing.

Authors:  Brendan A Palmer; Zoya Dimitrova; Pavel Skums; Orla Crosbie; Elizabeth Kenny-Walsh; Liam J Fanning
Journal:  J Virol       Date:  2014-09-17       Impact factor: 5.103

Review 8.  Viral evasion and challenges of hepatitis C virus vaccine development.

Authors:  Brian G Pierce; Zhen-Yong Keck; Steven Kh Foung
Journal:  Curr Opin Virol       Date:  2016-09-19       Impact factor: 7.090

9.  Sequence and functional analysis of the envelope glycoproteins of hepatitis C virus variants selectively transmitted to a new host.

Authors:  Valentina D'Arienzo; Alain Moreau; Louis D'Alteroche; Valérie Gissot; Emmanuelle Blanchard; Catherine Gaudy-Graffin; Emmanuelle Roch; Frédéric Dubois; Bruno Giraudeau; Jean-Christophe Plantier; Alain Goudeau; Philippe Roingeard; Denys Brand
Journal:  J Virol       Date:  2013-10-09       Impact factor: 5.103

10.  Sec24C-Dependent Transport of Claudin-1 Regulates Hepatitis C Virus Entry.

Authors:  Peiqi Yin; Ye Li; Leiliang Zhang
Journal:  J Virol       Date:  2017-08-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.